Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127093401 | 12709340 | 1 | I | 20160817 | 20160901 | 20160901 | EXP | AU-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-070085 | BRISTOL MYERS SQUIBB | BOYD I. THIAMAZOLE AND RHABDOMYOLYSIS. WHO PHARMACEUTICALS NEWSLETTER. 2016;4:17-23 | 33.00 | YR | M | Y | 0.00000 | 20160901 | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127093401 | 12709340 | 1 | PS | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Unknown | U | 9218 | ||||||||||
| 127093401 | 12709340 | 2 | SS | THIAMAZOLE | METHIMAZOLE | 1 | Unknown | Y | 0 | ||||||||||
| 127093401 | 12709340 | 3 | SS | ALPRAZOLAM. | ALPRAZOLAM | 1 | Unknown | U | 0 | ||||||||||
| 127093401 | 12709340 | 4 | SS | BISOPROLOL | BISOPROLOL | 1 | Unknown | U | 0 | ||||||||||
| 127093401 | 12709340 | 5 | SS | CANDESARTAN | CANDESARTAN | 1 | Unknown | U | 0 | ||||||||||
| 127093401 | 12709340 | 6 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | U | 0 | ||||||||||
| 127093401 | 12709340 | 7 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
| 127093401 | 12709340 | 8 | SS | PROPYLTHIOURACIL. | PROPYLTHIOURACIL | 1 | Unknown | U | 0 | ||||||||||
| 127093401 | 12709340 | 9 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127093401 | 12709340 | 1 | Product used for unknown indication |
| 127093401 | 12709340 | 2 | Product used for unknown indication |
| 127093401 | 12709340 | 3 | Product used for unknown indication |
| 127093401 | 12709340 | 4 | Product used for unknown indication |
| 127093401 | 12709340 | 5 | Product used for unknown indication |
| 127093401 | 12709340 | 6 | Product used for unknown indication |
| 127093401 | 12709340 | 7 | Product used for unknown indication |
| 127093401 | 12709340 | 8 | Product used for unknown indication |
| 127093401 | 12709340 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127093401 | 12709340 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127093401 | 12709340 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |